BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 37848532)

  • 1. Hallmark discoveries in the biology of Wilms tumour.
    Perotti D; Williams RD; Wegert J; Brzezinski J; Maschietto M; Ciceri S; Gisselsson D; Gadd S; Walz AL; Furtwaengler R; Drost J; Al-Saadi R; Evageliou N; Gooskens SL; Hong AL; Murphy AJ; Ortiz MV; O'Sullivan MJ; Mullen EA; van den Heuvel-Eibrink MM; Fernandez CV; Graf N; Grundy PE; Geller JI; Dome JS; Perlman EJ; Gessler M; Huff V; Pritchard-Jones K
    Nat Rev Urol; 2024 Mar; 21(3):158-180. PubMed ID: 37848532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms tumour: prognostic factors, staging, therapy and late effects.
    Kaste SC; Dome JS; Babyn PS; Graf NM; Grundy P; Godzinski J; Levitt GA; Jenkinson H
    Pediatr Radiol; 2008 Jan; 38(1):2-17. PubMed ID: 18026723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
    Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
    Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment of relapsing Wilms' tumour by autologous bone marrow transplantation.
    Kullendorff CM; Békássy AN
    Eur J Pediatr Surg; 1997 Jun; 7(3):177-9. PubMed ID: 9241510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumour: treatment of 113 patients from 1960 to 1971.
    Jenkin RD; Darte JM; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1975 Feb; 112(3):308-13. PubMed ID: 162847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic changes of Wilms tumour.
    Treger TD; Chowdhury T; Pritchard-Jones K; Behjati S
    Nat Rev Nephrol; 2019 Apr; 15(4):240-251. PubMed ID: 30705419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
    Ortiz MV; Ahmed S; Burns M; Henssen AG; Hollmann TJ; MacArthur I; Gunasekera S; Gaewsky L; Bradwin G; Ryan J; Letai A; He Y; Naranjo A; Chi YY; LaQuaglia M; Heaton T; Cifani P; Dome JS; Gadd S; Perlman E; Mullen E; Steen H; Kentsis A
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging in unilateral Wilms tumour.
    Brisse HJ; Smets AM; Kaste SC; Owens CM
    Pediatr Radiol; 2008 Jan; 38(1):18-29. PubMed ID: 18038168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and outcomes of patients with late recurrence of Wilms' tumor.
    Malogolowkin M; Spreafico F; Dome JS; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM; Bergeron C; de Kraker J; Graf N;
    Pediatr Blood Cancer; 2013 Oct; 60(10):1612-5. PubMed ID: 23737480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wilms' tumor: reached progress and future prospects].
    Tamaro P
    Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of bilateral Wilms tumours.
    Millar AJ; Cox S; Davidson A
    Pediatr Surg Int; 2017 Apr; 33(4):461-469. PubMed ID: 28054101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic variables in adult Wilms tumour.
    Izawa JI; Al-Omar M; Winquist E; Stitt L; Rodrigues G; Steele S; Siemens DR; Luke PP
    Can J Surg; 2008 Aug; 51(4):252-6. PubMed ID: 18815646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP; Bastin KT; Wiersma SR
    Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephroblastoma in children and adolescents - prognostic factors at diagnosis and in relapse].
    Marciniak P; Wachowiak J
    Med Wieku Rozwoj; 2009; 13(1):59-65. PubMed ID: 19648662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumour: diagnosis and treatment.
    Coppes MJ; Wolff JE; Ritchey ML
    Paediatr Drugs; 1999; 1(4):251-62. PubMed ID: 10935424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bilateral Wilms tumours.
    Millar AJW; Cox S; Davidson A
    Pediatr Surg Int; 2017 Jul; 33(7):737-745. PubMed ID: 28516188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the management of Wilms' tumour.
    Ahmed HU; Arya M; Tsiouris A; Sellaturay SV; Shergill IS; Duffy PG; Mushtaq I
    Eur J Surg Oncol; 2007 Sep; 33(7):824-31. PubMed ID: 17317082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the biology and treatment of Wilms' tumor.
    Ritchey ML
    Curr Urol Rep; 2001 Apr; 2(2):127-31. PubMed ID: 12084281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.